InvestSMART

Elixinol Wellness Limited (ASX:EXL)

ALERT: Price-sensitive ASX Announcement for EXL
Current share price for EXL : $0.006 -0.003 (-33.33%)+
Announcement
Release
27 Feb 2026 2:33PM
Price at Release
$0.009
Full Release
download
Summary
Elixinol Wellness Limited (ASX: EXL) reported its full-year results for FY25, emphasizing a repositioning for sustainable growth and margin expansion. The company achieved a revenue of $15.5 million, representing a 3.6% year-on-year increase, with significant growth of 163% in higher-margin e-commerce sales in Australia, largely driven by products from The Healthy Chef. Despite challenges in the US market due to regulatory uncertainties, Elixinol remained focused on strengthening its foundational operations, streamlining its brand portfolio, and concentrating on areas with the greatest long-term potential. The company improved its gross margin to 39% and achieved positive adjusted EBITDA in Q4 FY25. Elixinol also completed several capital management activities, including a $1.5 million debt and equity raise, to support its growth strategy. Looking forward, Elixinol aims to leverage its portfolio of brands in the high-growth nutrition and wellness category, with opportunities for organic growth and acquisitions to scale the business.
Key Points
  • FY25 revenue of $15.5m, up 3.6% year-on-year.
  • Significant growth in e-commerce sales in Australia, particularly from The Healthy Chef.
  • Gross margin increased to 39%, with a Q4 increase to 42%.
  • Positive adjusted EBITDA achieved in Q4 FY25.
  • Capital management activities raised $4m to support growth.
  • Challenges in the US market due to regulatory uncertainties.
  • Focus on strengthening the business foundation and brand portfolio.
  • Opportunities for growth in nutrition, wellness, and superfoods categories.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.